Categories: All postsAnalystsIT

Celestica is undervalued, says Canaccord Genuity

Assembling BlackBerrys used to be a big part of Celestica’s gig. But with that relationship having drawn to a close recently, the company is proving it can soldier on.

Canaccord Genuity analyst Robert Young says that despite an improving electronics manufacturing services sector, Celestica (Celestica Stock Quote, Chart, News: TSX, NYSE:CLS) still isn’t getting the love it deserves.

Shares of Celestica spiked late in January after the company announced fourth quarter 2016 revenue was (US) $1.62-billion, ahead of the company’s guidance range of $1.5 to $1.6-billion.

“Celestica delivered a strong fourth quarter, with growth in revenue of 7 per cent and growth in operating earnings of 16 per cent, compared with the fourth quarter of 2015,” said CEO Rob Mionis. “Celestica’s strong close to the year helped deliver full-year 2016 revenue growth of 7 per cent, 14-per-cent growth in operating earnings and over $100-million of free cash flow. Among the many highlights for 2016, we achieved our highest level of operating margins since 2001 and the highest revenue levels since 2012. We are proud of our many accomplishments this year. I am pleased with the progress we have made in setting the foundation for our strategy and delivering on our priorities, and I am excited about the momentum we are building as we continue to drive profitable growth and increase shareholder value.”

Young says Celestica is looking cheap compared to its peers, and thinks there is growth on the horizon for the company.

“The EMS neighborhood appears to be improving but despite strong quarterly performance, Celestica continues to trail its peers on valuation,” explains the analyst. “We believe that Celestica is at the beginning of a more aggressive phase of growth buoyed by an under-levered balance sheet which may be put to work on M&A as early as late 2017. We feel that the risk related to Celestica’s 70% mix of revenue from legacy businesses (collectively communications, server and storage) is lower than perceived given exposure to current optical trends and strength of Celestica’s differentiated JDM offering. Stronger double-digit growth is expected from the diversified segment, supplemented by acquisitions, but temporarily impeded by a 3% solar headwind, driving our outlook for 4-5% overall annual growth moving forward. In our view, there is potential for margin uplift from an increased mix of sticky, high-margin diversified business and as Celestica’s existing diversified footprint stabilizes. On the back of recent marketing meetings in the US Midwest, we have renewed confidence in this new phase of growth.

In a research update to clients Monday, Young maintained his “Buy” rating on Celestica, but raised his one-year price target from (US) $14.25 to $16.25, implying a return of 16.9 per cent at the time of publication.

Young thinks Celestica will post EBITDA of (US) $304.5-million on sales of $6.25-billion in fiscal 2017. He expects these numbers will improve to EBITDA of $311.9-million on a topline of $6.54-billion the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cls
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago